Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints Meeker CEO of Genzyme

Current chief operating officer of Genzyme, David Meeker, will take over as CEO of the company from November 1

Current chief operating officer of Genzyme, David Meeker, will take over as CEO of the company from November 1.

He was appointed by France-based pharmaceutical company Sanofi who purchased Genzyme in April 2011 for about $20bn.

Former Genzyme CEO, Henri A Termeer, who had spent 26 years in the position, left Genzyme following the takeover. The company had since been without a CEO until Meeker's appointment.

Christopher A Viehbacher, CEO of Sanofi, said: "After working closely with David over the past six months, I am confident that he is the best person to lead Genzyme. David's commitment to employees, physicians and patients has been a key success factor in the successful integration of Genzyme as part of the Sanofi Group."

Under Meeker's leadership, Genzyme will incorporate the rare disease business and the multiple sclerosis franchise.

Previous Genzyme divisions - renal, biosurgery and oncology - have been integrated within the existing Sanofi portfolio.

Meeker joined Genzyme in 1994 as medical director to work on the cystic fibrosis gene therapy programme. Other positions Meeker held at Genzyme include president of the global rare disease business.

25th October 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics